Antiviral 10-Q/A 19 May 14 2014 Q1 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	3 Months Ended
	Mar. 31, 2014
Document and Entity Information	'
Entity Registrant Name	'ANTIVIRAL TECHNOLOGIES, INC.
Document Type	'10-Q
Document Period End Date	31-Mar-14
Amendment Flag	'false
Entity Central Index Key	'0001445226
Current Fiscal Year End Date	'--12-31
Entity Common Stock, Shares Outstanding	150,000,000
Entity Public Float	$0
Entity Filer Category	'Smaller Reporting Company
Entity Current Reporting Status	'Yes
Entity Voluntary Filers	'No
Entity Well-known Seasoned Issuer	'No
Document Fiscal Year Focus	'2014
Document Fiscal Period Focus	'Q1

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$399	$499
Prepayments, deposits and other receivables	2	2
Total current assets	401	501
Non-current assets:	'	'
Property, plant and equipment, net	476	642
Patents, net	488,562	483,015
Total non-current assets	489,038	483,657
Total Assets	489,439	484,158
Current liabilities:	'	'
Accruals and other payables	174,004	176,110
Amount due to director, officer and stockholder	3,072,301	2,990,648
Total liabilities	3,246,305	3,166,758
Stockholders' equity/(deficit):	'	'
Preferred stock	0	0
Common stock	150,000	150,000
Additional paid-in capital	-144,858	-144,858
Accumulated other comprehensive income/(loss)	-10,047	-12,458
Deficit accumulated during the development stage	-2,751,961	-2,675,284
Total stockholders' equity/(deficit)	-2,756,866	-2,682,600
Total Liabilities and Shareholders' Equity	$489,439	$484,158

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	150,000,000	150,000,000
Common stock, shares outstanding	150,000,000	150,000,000

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		79 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Operating expenses:	'	'	'
Selling and distribution costs	'	$85	$53,827
General and administrative expenses	76,677	84,831	2,580,313
Loss from operations before other expenses	-76,677	-84,916	-2,634,140
Other expenses - net exchange gain/ (loss)	'	'	-95,224
Written off bad debt	'	'	-3,585
Preliminary expenses	'	'	-1,393
Interest income	'	'	14,343
Interest expense	'	'	-31,962
Net Loss	-76,677	-84,916	-2,751,961
Other comprehensive income:	'	'	'
Foreign currency translation gain/ (loss)	2,411	2,533	-10,047
Comprehensive Loss	($74,266)	($82,383)	($2,762,008)
Net loss per common share basic and diluted	$0	$0	$0.02
Weighted average number of shares basic and diluted	150,000,000	150,000,000	149,043,915

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (USD $)	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Total Stockholder Equity (Deficit)
Stockholder Equity at Sep. 12, 2007	'	$147,000	($146,999)	'	'	$1
Shares issued at Sep. 12, 2007	'	147,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	1,042	'	1,042
Net Loss	'	'	'	'	-319,416	-319,416
Stockholder Equity at Dec. 31, 2007	'	147,000	-146,999	1,042	-319,416	-318,373
Shares issued at Dec. 31, 2007	'	147,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	10	'	10
Net Loss	'	'	'	'	-310,453	-310,453
Stockholder Equity at Dec. 31, 2008	'	147,000	-146,999	1,052	-629,869	-628,816
Shares issued at Dec. 31, 2008	'	147,000,000	'	'	'	'
Reverse acquisition	'	3,000	2,141	'	'	5,141
Stock issued pursuant to reverse acquisition	'	3,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	492	'	492
Net Loss	'	'	'	'	-462,012	-462,012
Stockholder Equity at Dec. 31, 2009	'	150,000	-144,858	1,544	-1,091,881	-1,085,195
Shares issued at Dec. 31, 2009	'	150,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	2,600	'	2,600
Net Loss	'	'	'	'	-441,291	-441,291
Stockholder Equity at Dec. 31, 2010	'	150,000	-144,858	4,144	-1,533,172	-1,523,886
Shares issued at Dec. 31, 2010	'	150,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	-7,025	'	-7,025
Net Loss	'	'	'	'	-402,884	-402,884
Stockholder Equity at Dec. 31, 2011	'	150,000	-144,858	-2,881	-1,936,056	-1,933,795
Shares issued at Dec. 31, 2011	'	150,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	-5,439	'	-5,439
Net Loss	'	'	'	'	-363,282	-363,282
Stockholder Equity at Dec. 31, 2012	'	150,000	-144,858	-8,320	-2,299,338	-2,302,516
Shares issued at Dec. 31, 2012	'	150,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	-4,138	'	-8,320
Net Loss	'	'	'	'	-375,946	-375,946
Stockholder Equity at Dec. 31, 2013	-2,682,600	150,000	-144,858	-12,458	-2,675,284	-2,682,600
Shares issued at Dec. 31, 2013	'	150,000,000	'	'	'	'
Foreign currency translation adjustment	'	'	'	2,411	'	2,411
Net Loss	-76,677	'	'	'	-76,677	-76,677
Stockholder Equity at Mar. 31, 2014	($2,756,866)	$150,000	($144,858)	($10,047)	($2,751,961)	($2,756,866)
Shares issued at Mar. 31, 2014	'	150,000,000	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended		79 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Statement of Cash Flows	'	'	'
Net Loss	($76,677)	($84,916)	($2,751,961)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation	162	327	10,290
Amortization	4,197	3,305	48,972
Written off on patents	'	-618	54,223
Change in assets and liabilities:	'	'	'
(Increase)decrease in prepaid expenses, deposits	'	'	-2
Increase(decrease) in accruals	-2,106	16,420	173,514
Increase(decrease) in related party payables	'	'	490
Increase(decrease) in amounts due to directors and officers	55,173	54,271	1,149,462
Increase(decrease) in compensatory option issuances	'	'	560
Net cash used in operating activities	-19,251	-11,211	-1,314,452
Cash flows from investing activities:	'	'	'
Purchase of plant and equipment	43	-16	-10,986
Patent filing costs	-9,723	-10,126	-591,802
Net cash used in investing activities	-9,680	-10,142	-602,788
Cash flows from financing activities:	'	'	'
Amount due to stockholder	26,876	17,116	1,764,504
Director advancement	-396	1,599	185,335
Sales of common stock	'	'	21,000
Net cash provided by financing activities	26,480	18,715	1,943,839
Net increase/(decrease) in cash and cash equivalents	-2,451	-2,638	26,599	[1]
Effect of exchange rate changes on cash and cash equivalents	2,351	2,492	-26,200
Initial cash and cash equivalents	499	699	'
Final cash and cash equivalents	399	553	399
Supplemental disclosure of cash flow information:	'	'	'
Interest paid	'	'	$31,962
[1]	In 2009, the issuance of Common Stock for the acquisition of Obio (H.K.) of $147,000 by issuance of 147 million shares is not included in the Consolidated Cash Flow Statements due to non-cash in nature.

Basis_of_Presentation_Organiza

Basis of Presentation, Organization and Principal Activity	3 Months Ended
	Mar. 31, 2014
Notes	'
Basis of Presentation, Organization and Principal Activity	'
	NOTE 1.  BASIS OF PRESENTATION
	The accompanying unaudited financial statements of Antiviral Technologies, Inc. at March 31, 2014 and 2013 have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial statements, instructions to Form 10-Q and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2013. In management's opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make our financial statements not misleading have been included. The results of operations for the periods ended March 31, 2014 and 2013 presented are not necessarily indicative of the results to be expected for the full year. The December 31, 2013 balance sheet has been derived from the Company’s audited financial statements included in its annual report on Form 10-K for the year ended December 31, 2013.
	NOTE 2 Organization and principal activitY
	Antiviral Technologies, Inc. (“the Company”) was incorporated in the state of Nevada on September 13, 2007, as Table Mesa Acquisitions, Inc., and on October 13, 2009, changed its name to Antiviral Technologies, Inc.  On October 14, 2009, the Company acquired Obio Pharmaceutical (H.K.) Ltd (“Obio HK”), and its wholly-owned subsidiary, Beijing Obio Pharmaceutical Co., Ltd (“Beijing Obio”) in a share exchange transaction (the “Share Exchange”). This transaction was accounted for as a “reverse merger” with Obio HK deemed to be the accounting acquirer and the Company as the legal acquirer.  Consequently, the assets and liabilities and the historical operations that are reflected in the financial statements for periods prior to the Share Exchange are those of Obio HK, recorded at its historical cost basis. After completion of the Share Exchange, the Company’s consolidated financial statements include the assets and liabilities of the Company and Obio HK, the historical operations of Obio HK and the operations of the Company and its subsidiaries from the closing date of the Share Exchange.
	Obio HK is a Hong Kong corporation which was formed on June 28, 1999 as Pacific Cosmos Investment Limited. After formation, it had several name changes including a change to J & P Capital (Hong Kong) Limited, on August 27, 1999, a change to Omega-Pharma (Hong Kong) Limited, on May 21, 2003, a change to Omega-BioPharma (HK) Limited, on December 10, 2003, and finally, a change to its current name, Obio Pharmaceutical (H.K.) Limited, on March 2, 2009.
	Beijing Obio was incorporated under the laws of the PRC as a limited company on January 2, 2008.
	The Company and its subsidiaries (hereinafter, collectively referred to as the “Group”) are engaged in human pharmaceutical research and development..

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk and Major Customers	3 Months Ended
	Mar. 31, 2014
Notes	'
Concentrations of Credit Risk and Major Customers	'
	NOTE 3  CONCENTRATIONS OF CREDIT RISK AND MAJOR CUSTOMERS
	Financial instruments which potentially expose the Company to concentrations of credit risk, consists of cash and other receivables as of March 31, 2014 and 2013. The Company performs ongoing evaluations of its cash position and credit evaluations to ensure collections and minimize losses.
	As of March 31, 2014 and 2013, the Company’s bank deposits were all placed with banks in Hong Kong and the PRC where there is currently no rule or regulation in place for obligatory insurance of bank accounts.
	The maximum amount of loss due to credit risk that the Company would incur if the counter parties to the financial instruments failed to perform is represented the carrying amount of each financial asset in the balance sheet.

Uncertainty_of_Ability_To_Cont

Uncertainty of Ability To Continue As A Going Concern	3 Months Ended
	Mar. 31, 2014
Notes	'
Uncertainty of Ability To Continue As A Going Concern	'
	NOTE 4 UNCERTAINTY OF ABILITY TO CONTINUE AS A GOING CONCERN
	The Company's financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not generated revenues since inception and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. The continuation of the Company as a going concern is dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations.
	As of March 31, 2014, the Company has not generated any revenue and has incurred an accumulated deficit since inception totaling $2,751,961at March 31, 2014 and its current liabilities exceed its current assets by $3,245,904. These financial statements do not include any adjustments relating to the classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These factors noted above raise substantial doubts regarding the Company's ability to continue as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
Notes	'
Summary of Significant Accounting Policies	'
	NOTE 5 Summary of significant accounting policies
	(a)               Principles of consolidation
	The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiary.  All significant inter-company balances and transactions are eliminated in consolidation.
	The Company owned its subsidiary soon after its inception and continued to own the equity’s interests through March 31, 2014.  The following table depicts the identity of the subsidiary:
		Place of	Attributable equity	Registered
	Name of subsidiary	Incorporation	interest %	capital
	Obio Pharmaceutical (H.K.) Ltd	Hong Kong	100	$1
	Beijing Obio Pharmaceutical Co., Ltd	PRC	100	$200,000
	(b)               Use of estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.  Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates.
	(c)                Economic and political risks
	The Company’s operation is conducted in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the PRC, and by the general state of the PRC economy.
	The Company’s operations in the PRC are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation, among other things.
	(d)               Property, plant and equipment
	Plant and equipment are carried at cost less accumulated depreciation.  Depreciation is provided over their estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:
	Office equipment             5 years
	Testing equipment            5 years
	The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statement of operation.
	(e)                Patents
	Patents that are acquired by the Company and/or self-invented are stated as cost less accumulated amortization. Amortization is provided over the respective useful lives, using the straight-line method.  Estimated useful lives of the patents are 20 years from the date the patent is filed.
	(f)                 Accounting for the impairment of long-lived assets
	The Company periodically evaluates the carrying value of long-lived assets to be held and used, including intangible assets subject to amortization, when events and circumstances warrant such a review, pursuant to the guidelines established in ASC No. 360. The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair market values are reduced for the cost to dispose.
	During the reporting years, there was no impairment loss.
	(g)               Cash and cash equivalents
	The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. The Company maintains bank accounts in the Hong Kong. The subsidiaries of the Company maintain bank accounts in Hong Kong and the PRC.
	(h)               Income taxes
	The Company accounts for income taxes in interim periods in accordance with ASC Topic 740, Income Taxes (“ASC 740”).  We have determined an estimated annual effective tax rate.  The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate.  As of March 31, 2014, the estimated effective tax rate for the year will be zero.
	ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.
	(i)                 Foreign currency translation
	The accompanying consolidated financial statements are presented in United States dollars. The functional currency of the Company is the Hong Kong Dollar (HKD) and Renminbi (RMB). The consolidated financial statements are translated into United States dollars from RMB at period-end exchange rates as to assets and liabilities and average exchange rates as to revenues and expenses. Capital accounts are translated at their historical exchange rates when the capital transactions occurred.
	The exchange rates used to translate amounts in HKD and RMB into USD for the purposes of preparing the consolidated financial statements were as follows:
			31-Mar-14		December 31, 2013	31-Mar-13
	Twelve months ended		-		7.7548	-
	HKD : USD exchange rate
	Three months ended		7.7584		-	7.7641
	HKD : USD exchange rate
	Average three months ended		7.75922		-	7.75613
	HKD : USD exchange rate
	Twelve months ended		-		6.114	-
	RMB : USD exchange rate
	Three months ended		6.1644		-	6.2816
	RMB : USD exchange rate
	Average three months ended		6.11985		-	6.28582
	RMB : USD exchange rate
	The RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions.  No representation is made that the RMB amounts could have been, or could be, converted into USD at the rates used in translation. In addition, the current foreign exchange control policies applicable in PRC also restrict the transfer of assets or dividends outside the PRC.
	(j)                 Per Share Information
	Earnings per share are based on the weighted average number of shares outstanding during the period after consideration of the dilutive effect, if any, for common stock equivalents, including stock options, restricted stock, and other stock-based compensation. Earnings per common share are computed in accordance with ASC Topic 260, Earnings Per Share, which requires companies to present basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share are computed by dividing net income by the weighted average number of shares of common stock outstanding and dilutive securities outstanding during the year.  We had a net loss for the three-month periods ended March 31, 2014 and 2013, and accordingly, any outstanding equivalents would be anti-dilutive.
	(k)        Recently implemented standards
	In January 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies that ordinary trade receivables and receivables are not in the scope of ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities. Specifically, ASU 2011-11 applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in the FASB Accounting Standards Codification (Codification) or subject to a master netting arrangement or similar agreement. The FASB undertook this clarification project in response to concerns expressed by U.S. stakeholders about the standard’s broad definition of financial instruments. After the standard was finalized, companies realized that many contracts have standard commercial provisions that would equate to a master netting arrangement, significantly increasing the cost of compliance at minimal value to financial statement users. An entity is required to apply the amendments in ASU 2013-01 for fiscal years beginning on or after January 1, 2013, and interim periods within those annual periods. An entity should provide the required disclosures retrospectively for all comparative periods presented. The effective date is the same as the effective date of ASU 2011-11.
	In February 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This ASU improves the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in this ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP.
	The new amendments will require an organization to:
	·         Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.
	·         Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). A private company is required to meet the reporting requirements of the amended paragraphs about the roll forward of accumulated other comprehensive income for both interim and annual reporting periods. However, private companies are only required to provide the information about the effect of reclassifications on line items of net income for annual reporting periods, not for interim reporting periods. The amendments are effective for reporting periods beginning after December 15, 2012, for public companies and are effective for reporting periods beginning after December 15, 2013, for private companies. Early adoption is permitted.
	In February 2013, FASB issued Accounting Standards Update (ASU) No. 2013-03, Financial Instruments (Topic 825). This ASU clarifies the scope and applicability of a disclosure exemption that resulted from the issuance of Accounting Standards Update No. 2011-04,Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. The amendment clarifies that the requirement to disclose "the level of the fair value hierarchy within which the fair value measurements are categorized in their entirety (Level 1, 2, or 3)" does not apply to nonpublic entities for items that are not measured at fair value in the statement of financial position, but for which fair value is disclosed. This ASU is the final version of Proposed Accounting Standards Update 2013-200—Financial Instruments (Topic 825) which has been deleted. The amendments are effective upon issuance.
	In February 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-04, Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date. This ASU provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this ASU is fixed at the reporting date, except for obligations addressed within existing guidance in U.S. GAAP. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance in this ASU also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years ending after December 15, 2014, and interim periods and annual periods thereafter. The amendments in this ASU should be applied retrospectively to all prior periods presented for those obligations resulting from joint and several liability arrangements within the ASU’s scope that exist at the beginning of an entity’s fiscal year of adoption. An entity may elect to use hindsight for the comparative periods (if it changed its accounting as a result of adopting the amendments in this ASU) and should disclose that fact. Early adoption is permitted.
	In March 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-05, Foreign Currency Matters (Topic 830). This ASU resolve the diversity in practice about whether Subtopic 810-10, Consolidation—Overall, or Subtopic 830-30, Foreign Currency Matters—Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights)within a foreign entity. In addition, the amendments in this Update resolve the diversity in practice for the treatment of business combinations achieved in stages (sometimes also referred to as step acquisitions) involving a foreign entity. This ASU is the final version of Proposed Accounting Standards Update EITF11Ar—Foreign Currency Matters (Topic 830), which has been deleted. The amendments in this Update are effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. For nonpublic entities the amendments in this Update are effective prospectively for the first annual period beginning after December 15, 2014, and interim and annual periods thereafter. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted. Early adoption is permitted. If an entity elects to early adopt the amendments, it should apply them as of the beginning of the entity’s fiscal year of adoption.
	In April 2013, FASB Accounting Standards Update 2013-06, Not-for-Profit Entities (Topic 958) - Services Received from Personnel of an Affiliate. This ASU specifies the guidance that not-for-profit entities apply for recognizing and measuring services received from personnel of an affiliate. More specifically, the amendments in this ASU apply to not-for-profit entities, including not-for-profit, business-oriented health care entities that receive services from personnel of an affiliate that directly benefit the recipient not-for-profit entity and for which the affiliate does not charge the recipient not-for-profit entity. The amendments in this ASU require a recipient not-for-profit entity to recognize all services received from personnel of an affiliate that directly benefit the recipient not-for-profit entity. Those services should be measured at the cost recognized by the affiliate for the personnel providing those services. However, if measuring a service received from personnel of an affiliate at cost will significantly overstate or understate the value of the service received, the recipient not-for-profit entity may elect to recognize that service received at either: (a) the cost recognized by the affiliate for the personnel providing that service or; (b) the fair value of that service. The amendments in this ASU are effective prospectively for fiscal years beginning after June 15, 2014, and interim and annual periods thereafter. A recipient not-for-profit entity may apply the amendments using a modified retrospective approach under which all prior periods presented upon the date should be adjusted, but no adjustment should be made to the beginning balance of net assets of the earliest period presented. Early adoption is permitted.
	In April 2013, FASB Accounting Standards Update 2013-07, Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting. This ASU clarifies when an entity should apply the liquidation basis of accounting. In addition, the guidance provides principles for the recognition and measurement of assets and liabilities and requirements for financial statements prepared using the liquidation basis of accounting. Liquidation is the process by which a company converts its assets to cash or other assets and settles its obligations with creditors in anticipation of ceasing all of its activities. An organization in liquidation must prepare its financial statements using a basis of accounting that communicates information to users of those financial statements to enable those users to develop expectations about how much the organization will have available for distribution to investors after disposing of its assets and settling its obligations. The ASU requires organization to prepare its financial statements using the liquidation basis of accounting when liquidation is “imminent.” Liquidation is considered imminent when the likelihood is remote that the organization will return from liquidation and either: (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties; or (b) a plan for liquidation is being imposed by other forces (e.g., involuntary bankruptcy). In cases where a plan for liquidation was specified in the organization’s governing documents at inception (e.g., limited-life entities), the organization should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified in the organization’s governing documents. The ASU requires financial statements prepared using the liquidation basis to present relevant information about a company’s resources and obligations in liquidation, including the following:
	·         The organization’s assets measured at the amount of the expected cash proceeds from liquidation, including any items it had not previously recognized under U.S. GAAP that it expects to either sell in liquidation or use in settling liabilities (e.g., trademarks).
	·         The organization’s liabilities as recognized and measured in accordance with existing guidance that applies to those liabilities.
	·         Accrual of the costs it expects to incur and the income it expects to earn during liquidation, including any anticipated disposal costs.
	This ASU is effective for interim and annual reporting periods beginning after December 15, 2013, with early adoption permitted.
In June 2013, FASB Accounting Standards Update 2013-08, Financial Services—Investment Companies (Topic 946): Amendments to the Scope, Measurement, and Disclosure Requirements. This ASU sets forth a new approach for determining whether a public or private company is an investment company. The ASU also clarifies the characteristics and sets measurement and disclosure requirements for an investment company. The ASU is effective for fiscal years beginning after December 15, 2013. Early adoption is not allowed.
This guidance is a result of the efforts of the FASB and the IASB to develop a consistent approach for determining whether a company is an investment company, for which fair value of investments is the most relevant measurement for the company’s financial statement users. The ASU affects the scope, measurement, and disclosure requirements for investment companies under U.S. GAAP.
Under the ASU, a company regulated under the Investment Company Act of 1940 is considered an investment company for accounting purposes. All other companies must assess whether they have the following characteristics to be considered an investment company:
(a) The company obtains funds from investor(s) and provides the investor(s) with investment management services;
(b) The company commits to its investor(s) that its business purpose and only substantive activities are investing the funds for returns solely from capital appreciation, investment income, or both;
(c) The company or its affiliates do not obtain or have the objective of obtaining returns or benefits from an investee or its affiliates that are not normally attributable to ownership interests or that are other than capital appreciation or investment income;
(d) The company has multiple investments;
(e) The company has multiple investors;
(f) The company has investors that are not related to the parent or investment manager;
(g) The company’s ownership interests are in the form of equity or partnership interests; and
(h) The company manages substantially all of its investments on a fair value basis.
To be considered an investment company, a company must have all the fundamental characteristics of (a) through (c) above. Typically, an investment company also has characteristics (d) through (h). However, if a company does not possess one or more of the typical characteristics, it must apply judgment and determine, considering all facts and circumstances, how its activities continue to be consistent (or are not consistent) with those of an investment company.
An investment company also will be required to measure noncontrolling ownership interests in other investment companies at fair value rather than using the equity method of accounting. In addition, an investment company will be required to make the following additional disclosures: (a) the fact that the company is an investment company and is applying specialized guidance; (b) information about changes, if any, in a company’s status as an investment company; and (c) information about financial support provided or contractually required to be provided by an investment company to any of its investees.
In July 2013, The FASB has published Accounting Standards Update 2013-09, Fair Value Measurement (Topic 820): Deferral of the Effective Date of Certain Disclosures for Nonpublic Employee Benefit Plans in Update No. 2011-04. This ASU defers indefinitely certain disclosures about investments held by nonpublic employee benefit plans in their plan sponsors’ own nonpublic equity securities. The ASU was approved by the FASB on June 12, 2013. ASU No. 2013-09, Fair Value Measurement (Topic 820): Deferral of the Effective Date of Certain Disclosures for Nonpublic Employee Benefit Plans in Update No. 2011-04, applies to disclosures of certain quantitative information about the significant unobservable inputs used in Level 3 fair value measurement for investments held by certain employee benefit plans.
In July 2013, The FASB has issued Accounting Standards Update (ASU) No. 2013-10, Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (a consensus of the FASB Emerging Issues Task Force). The amendments in this ASU permit the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to UST and LIBOR. The amendments also remove the restriction on using different benchmark rates for similar hedges.
Before the amendments in this ASU, only UST and, for practical reasons, the LIBOR swap rate, were considered benchmark interest rates. Including the Fed Funds Effective Swap Rate (OIS) as an acceptable U.S. benchmark interest rate in addition to UST and LIBOR will provide risk managers with a more comprehensive spectrum of interest rate resets to utilize as the designated benchmark interest rate risk component under the hedge accounting guidance.
The amendments apply to all entities that elect to apply hedge accounting of the benchmark interest rate. The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013.
In July 2013, The FASB has issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force).
U.S. GAAP does not include explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The amendments in this ASU state that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.
This ASU applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted.
In March 2014, FASB has issued Accounting Standards Update (ASU) No. 2014-07, Applying Variable Interest Entities Guidance to Common Control Leasing Arrangements. The guidance addresses the consolidation of lessors in certain common control leasing arrangements and is based on a consensus reached by the Private Company Council (PCC). Under current U.S. GAAP, a company is required to consolidate an entity in which it has a controlling financial interest. The assessment of controlling financial interest is performed under either: (a) a voting interest model; or (b) a variable interest entity model. In a variable interest entity model, the company has a controlling financial interest when it has: (a) the power to direct the activities that most significantly affect the economic performance of the entity; and (b) the obligation to absorb losses or the right to receive benefits of the entity that could be potentially significant to the entity. To determine which model applies, a company preparing financial statements must first determine whether it has a variable interest in the entity being evaluated for consolidation and whether that entity is a variable interest entity. If elected, the accounting alternative should be applied to all leasing arrangements meeting the above conditions. The alternative should be applied retrospectively to all periods presented, and is effective for annual periods beginning after December 15, 2014, and interim periods within annual periods beginning after December 15, 2015. Early application is permitted for all financial statements that have not yet been made available for issuance.
Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Property_Plant_and_Equipment_N

Property, Plant and Equipment, Net	3 Months Ended
	Mar. 31, 2014
Notes	'
Property, Plant and Equipment, Net	'
	NOTE 6 PROPERTY, PLANT AND EQUIPMENT, NET
	Property and equipment is summarized as follows:
			As of March 31, 2014		As of December 31, 2013
			-----------------------		-----------------------
	Cost
	Plant and Machinery	$	3,891	$	3,893
	Furniture, fixtures and equipment		1,810		1,825
	Office equipment		5,285		5,311
			-----------------------		-----------------------
			10,986		11,029
	Accumulated depreciation		-10,510		-10,387
			-----------------------		-----------------------
		$	476	$	642
			=====		=====
	Depreciation expenses included in the general and administrative expenses for the three months ended March 31, 2014 and for the year ended December 31, 2013 were $162 and $995.

Patents_Net

Patents, Net	3 Months Ended
	Mar. 31, 2014
Notes	'
Patents, Net	'
	NOTE 7 PATENTS, NET
	Patents are summarized as follows:
			As of March 31, 2014		As of December 31, 2013
			----------------------------		---------------------------
	Cost
	Patents	$	470,555	$	460,801
	License		67,024		67,055
			-----------------------		-----------------------
			537,579		527,856
	Accumulated amortization		-49,017		-44,841
			-----------------------		-----------------------
		$	488,562	$	483,015
			=====		=====
	Amortization included in the general and administrative expenses for the three months ended March 31, 2014 and for the year ended December 31, 2013 were $4,197 and $15,162.
	Written off on patents included in the general and administrative expenses for the period September 13, 2007 (Inception) to March 31, 2014 was $54,223.

Amounts_Due_To_Directors_Offic

Amounts Due To Directors, Officers and Shareholder	3 Months Ended
	Mar. 31, 2014
Notes	'
Amounts Due To Directors, Officers and Shareholder	'
	NOTE 8 AMOUNTS DUE TO DIRECTORS AND OFFICERS
	Amounts due to directors and officers were the amount due to Mr. Francis Chi, Director, Dr. Bill Piu Chan, Director and Chief Executive Officer, Mr. Kin Chung Cheng, Director and Chief Financial Officer and Dr. Jess Gilbert Thoene, Director and Chief Technical Officer and was unsecured, interest free and repayable upon completion of any fund raising exercise of Obio HK or ATI. The balances due to directors and officers are $1,307,797 and $1,253,020 as of March 31, 2014 and December 31 2013 respectively.
	NOTE 9 AMOUNT DUE TO THE SHAREHOLDER
	Amount due to the shareholder was unsecured, interest free and does not have a fixed repayment date.

Common_Stock

Common Stock	3 Months Ended
	Mar. 31, 2014
Notes	'
Common Stock	'
	NOTE 10  COMMON STOCK
	As a result of the share exchange transaction on October 14, 2009, which is being accounted for as a “reverse merger,” the Group’s capital structure has changed. Following completion of the share exchange transaction, the Company has a total of 150,000,000 shares of $0.001 par value common stock issued and outstanding.  Common stock recorded was $150,000 with additional paid-in capital of ($144,858).

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Notes	'
Related Party Transactions	'
	NOTE 11 RELATED PARTY TRANSACTIONS
	In the normal course of its business, the group carried out the following related party transactions during the three months ended March 31, 2014 and 2013.
			31-Mar-14		31-Mar-13
	Company secretarial fee paid to related parties (a)	$	507	$	503
	(a)        The company secretarial fee was paid to related companies controlled by Chan Kin Man, Eddie, a director of the shareholder.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2014
Notes	'
Fair Value of Financial Instruments	'
	NOTE 12 FAIR VALUE OF FINANCIAL INSTRUMENTS
	ASC Topic 820, “Fair Value Measurements and Disclosures” ("ASC 820"), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.
	Level 2 - Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.
	Level 3 - Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.
	The Company’s financial instruments consist of cash and cash equivalents, payables, and amounts due to officers, directors and stockholder. The carrying values of cash and cash equivalents, payables, and amounts due to officers, directors and stockholder approximate their fair value due to their short maturities.

Segment_Information

Segment Information	3 Months Ended
	Mar. 31, 2014
Notes	'
Segment Information	'
	NOTE 13 SEGMENT INFORMATION
	The Company is principally engaged in business of human pharmaceutical research and development.  No significant revenues are derived during the reporting periods. Accordingly, no analysis of the Company’s sales and assets by geographical market is presented.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2014
Notes	'
Subsequent Events	'
	NOTE 14 SUBSEQUENT EVENTS
	In preparing these financial statements, the Company evaluated the events and transactions that occurred from April 1, 2014, through May 13, 2014, the date these financial statements were issued. The Company has made the required additional disclosures in reporting periods in which subsequent events occur.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Principles of Consolidation	'
	(a)               Principles of consolidation
	The consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiary.  All significant inter-company balances and transactions are eliminated in consolidation.
	The Company owned its subsidiary soon after its inception and continued to own the equity’s interests through March 31, 2014.  The following table depicts the identity of the subsidiary:
		Place of	Attributable equity	Registered
	Name of subsidiary	Incorporation	interest %	capital
	Obio Pharmaceutical (H.K.) Ltd	Hong Kong	100	$1
	Beijing Obio Pharmaceutical Co., Ltd	PRC	100	$200,000

Summary_of_Significant_Account2

Summary of Significant Accounting Policies: Use of Estimates (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Use of Estimates	'
	(b)               Use of estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.  Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates.

Summary_of_Significant_Account3

Summary of Significant Accounting Policies: Economic and Political Risks (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Economic and Political Risks	'
	(c)                Economic and political risks
	The Company’s operation is conducted in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environment in the PRC, and by the general state of the PRC economy.
	The Company’s operations in the PRC are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company’s results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation, among other things.

Summary_of_Significant_Account4

Summary of Significant Accounting Policies: Property, Plant and Equipment (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Property, Plant and Equipment	'
	(d)               Property, plant and equipment
	Plant and equipment are carried at cost less accumulated depreciation.  Depreciation is provided over their estimated useful lives, using the straight-line method. Estimated useful lives of the plant and equipment are as follows:
	Office equipment             5 years
	Testing equipment            5 years
	The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statement of operation.

Summary_of_Significant_Account5

Summary of Significant Accounting Policies: Patents (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Patents	'
	(e)                Patents
	Patents that are acquired by the Company and/or self-invented are stated as cost less accumulated amortization. Amortization is provided over the respective useful lives, using the straight-line method.  Estimated useful lives of the patents are 20 years from the date the patent is filed.

Summary_of_Significant_Account6

Summary of Significant Accounting Policies: Accounting For The Impairment of Long-lived Assets (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Accounting For The Impairment of Long-lived Assets	'
	(f)                 Accounting for the impairment of long-lived assets
	The Company periodically evaluates the carrying value of long-lived assets to be held and used, including intangible assets subject to amortization, when events and circumstances warrant such a review, pursuant to the guidelines established in ASC No. 360. The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair market values are reduced for the cost to dispose.
	During the reporting years, there was no impairment loss.

Summary_of_Significant_Account7

Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Cash and Cash Equivalents	'
	(g)               Cash and cash equivalents
	The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. The Company maintains bank accounts in the Hong Kong. The subsidiaries of the Company maintain bank accounts in Hong Kong and the PRC.

Summary_of_Significant_Account8

Summary of Significant Accounting Policies: Income Taxes (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Income Taxes	'
	(h)               Income taxes
	The Company accounts for income taxes in interim periods in accordance with ASC Topic 740, Income Taxes (“ASC 740”).  We have determined an estimated annual effective tax rate.  The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate.  As of March 31, 2014, the estimated effective tax rate for the year will be zero.
	ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

Summary_of_Significant_Account9

Summary of Significant Accounting Policies: Foreign Currency Translation (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Foreign Currency Translation	'
	(i)                 Foreign currency translation
	The accompanying consolidated financial statements are presented in United States dollars. The functional currency of the Company is the Hong Kong Dollar (HKD) and Renminbi (RMB). The consolidated financial statements are translated into United States dollars from RMB at period-end exchange rates as to assets and liabilities and average exchange rates as to revenues and expenses. Capital accounts are translated at their historical exchange rates when the capital transactions occurred.
	The exchange rates used to translate amounts in HKD and RMB into USD for the purposes of preparing the consolidated financial statements were as follows:
		31-Mar-14	December 31, 2013	31-Mar-13
	Twelve months ended	-	7.7548	-
	HKD : USD exchange rate
	Three months ended	7.7584	-	7.7641
	HKD : USD exchange rate
	Average three months ended	7.75922	-	7.75613
	HKD : USD exchange rate
	Twelve months ended	-	6.114	-
	RMB : USD exchange rate
	Three months ended	6.1644	-	6.2816
	RMB : USD exchange rate
	Average three months ended	6.11985	-	6.28582
	RMB : USD exchange rate
	The RMB is not freely convertible into foreign currency and all foreign exchange transactions must take place through authorized institutions.  No representation is made that the RMB amounts could have been, or could be, converted into USD at the rates used in translation. In addition, the current foreign exchange control policies applicable in PRC also restrict the transfer of assets or dividends outside the PRC.

Recovered_Sheet1

Summary of Significant Accounting Policies: Per Share Information (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Per Share Information	'
	(j)                 Per Share Information
	Earnings per share are based on the weighted average number of shares outstanding during the period after consideration of the dilutive effect, if any, for common stock equivalents, including stock options, restricted stock, and other stock-based compensation. Earnings per common share are computed in accordance with ASC Topic 260, Earnings Per Share, which requires companies to present basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share are computed by dividing net income by the weighted average number of shares of common stock outstanding and dilutive securities outstanding during the year.  We had a net loss for the three-month periods ended March 31, 2014 and 2013, and accordingly, any outstanding equivalents would be anti-dilutive.

Recovered_Sheet2

Summary of Significant Accounting Policies: Recently Implemented Standards (Policies)	3 Months Ended
	Mar. 31, 2014
Policies	'
Recently Implemented Standards	'
	(k)        Recently implemented standards
	In January 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. This ASU clarifies that ordinary trade receivables and receivables are not in the scope of ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities. Specifically, ASU 2011-11 applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in the FASB Accounting Standards Codification (Codification) or subject to a master netting arrangement or similar agreement. The FASB undertook this clarification project in response to concerns expressed by U.S. stakeholders about the standard’s broad definition of financial instruments. After the standard was finalized, companies realized that many contracts have standard commercial provisions that would equate to a master netting arrangement, significantly increasing the cost of compliance at minimal value to financial statement users. An entity is required to apply the amendments in ASU 2013-01 for fiscal years beginning on or after January 1, 2013, and interim periods within those annual periods. An entity should provide the required disclosures retrospectively for all comparative periods presented. The effective date is the same as the effective date of ASU 2011-11.
	In February 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This ASU improves the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in this ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP.
	The new amendments will require an organization to:
	·         Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.
	·         Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). A private company is required to meet the reporting requirements of the amended paragraphs about the roll forward of accumulated other comprehensive income for both interim and annual reporting periods. However, private companies are only required to provide the information about the effect of reclassifications on line items of net income for annual reporting periods, not for interim reporting periods. The amendments are effective for reporting periods beginning after December 15, 2012, for public companies and are effective for reporting periods beginning after December 15, 2013, for private companies. Early adoption is permitted.
	In February 2013, FASB issued Accounting Standards Update (ASU) No. 2013-03, Financial Instruments (Topic 825). This ASU clarifies the scope and applicability of a disclosure exemption that resulted from the issuance of Accounting Standards Update No. 2011-04,Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. The amendment clarifies that the requirement to disclose "the level of the fair value hierarchy within which the fair value measurements are categorized in their entirety (Level 1, 2, or 3)" does not apply to nonpublic entities for items that are not measured at fair value in the statement of financial position, but for which fair value is disclosed. This ASU is the final version of Proposed Accounting Standards Update 2013-200—Financial Instruments (Topic 825) which has been deleted. The amendments are effective upon issuance.
	In February 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-04, Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date. This ASU provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this ASU is fixed at the reporting date, except for obligations addressed within existing guidance in U.S. GAAP. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance in this ASU also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years ending after December 15, 2014, and interim periods and annual periods thereafter. The amendments in this ASU should be applied retrospectively to all prior periods presented for those obligations resulting from joint and several liability arrangements within the ASU’s scope that exist at the beginning of an entity’s fiscal year of adoption. An entity may elect to use hindsight for the comparative periods (if it changed its accounting as a result of adopting the amendments in this ASU) and should disclose that fact. Early adoption is permitted.
	In March 2013, FASB has issued Accounting Standards Update (ASU) No. 2013-05, Foreign Currency Matters (Topic 830). This ASU resolve the diversity in practice about whether Subtopic 810-10, Consolidation—Overall, or Subtopic 830-30, Foreign Currency Matters—Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights)within a foreign entity. In addition, the amendments in this Update resolve the diversity in practice for the treatment of business combinations achieved in stages (sometimes also referred to as step acquisitions) involving a foreign entity. This ASU is the final version of Proposed Accounting Standards Update EITF11Ar—Foreign Currency Matters (Topic 830), which has been deleted. The amendments in this Update are effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. For nonpublic entities the amendments in this Update are effective prospectively for the first annual period beginning after December 15, 2014, and interim and annual periods thereafter. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted. Early adoption is permitted. If an entity elects to early adopt the amendments, it should apply them as of the beginning of the entity’s fiscal year of adoption.
	In April 2013, FASB Accounting Standards Update 2013-06, Not-for-Profit Entities (Topic 958) - Services Received from Personnel of an Affiliate. This ASU specifies the guidance that not-for-profit entities apply for recognizing and measuring services received from personnel of an affiliate. More specifically, the amendments in this ASU apply to not-for-profit entities, including not-for-profit, business-oriented health care entities that receive services from personnel of an affiliate that directly benefit the recipient not-for-profit entity and for which the affiliate does not charge the recipient not-for-profit entity. The amendments in this ASU require a recipient not-for-profit entity to recognize all services received from personnel of an affiliate that directly benefit the recipient not-for-profit entity. Those services should be measured at the cost recognized by the affiliate for the personnel providing those services. However, if measuring a service received from personnel of an affiliate at cost will significantly overstate or understate the value of the service received, the recipient not-for-profit entity may elect to recognize that service received at either: (a) the cost recognized by the affiliate for the personnel providing that service or; (b) the fair value of that service. The amendments in this ASU are effective prospectively for fiscal years beginning after June 15, 2014, and interim and annual periods thereafter. A recipient not-for-profit entity may apply the amendments using a modified retrospective approach under which all prior periods presented upon the date should be adjusted, but no adjustment should be made to the beginning balance of net assets of the earliest period presented. Early adoption is permitted.
	In April 2013, FASB Accounting Standards Update 2013-07, Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting. This ASU clarifies when an entity should apply the liquidation basis of accounting. In addition, the guidance provides principles for the recognition and measurement of assets and liabilities and requirements for financial statements prepared using the liquidation basis of accounting. Liquidation is the process by which a company converts its assets to cash or other assets and settles its obligations with creditors in anticipation of ceasing all of its activities. An organization in liquidation must prepare its financial statements using a basis of accounting that communicates information to users of those financial statements to enable those users to develop expectations about how much the organization will have available for distribution to investors after disposing of its assets and settling its obligations. The ASU requires organization to prepare its financial statements using the liquidation basis of accounting when liquidation is “imminent.” Liquidation is considered imminent when the likelihood is remote that the organization will return from liquidation and either: (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties; or (b) a plan for liquidation is being imposed by other forces (e.g., involuntary bankruptcy). In cases where a plan for liquidation was specified in the organization’s governing documents at inception (e.g., limited-life entities), the organization should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified in the organization’s governing documents. The ASU requires financial statements prepared using the liquidation basis to present relevant information about a company’s resources and obligations in liquidation, including the following:
	·         The organization’s assets measured at the amount of the expected cash proceeds from liquidation, including any items it had not previously recognized under U.S. GAAP that it expects to either sell in liquidation or use in settling liabilities (e.g., trademarks).
	·         The organization’s liabilities as recognized and measured in accordance with existing guidance that applies to those liabilities.
	·         Accrual of the costs it expects to incur and the income it expects to earn during liquidation, including any anticipated disposal costs.
	This ASU is effective for interim and annual reporting periods beginning after December 15, 2013, with early adoption permitted.
	In June 2013, FASB Accounting Standards Update 2013-08, Financial Services—Investment Companies (Topic 946): Amendments to the Scope, Measurement, and Disclosure Requirements. This ASU sets forth a new approach for determining whether a public or private company is an investment company. The ASU also clarifies the characteristics and sets measurement and disclosure requirements for an investment company. The ASU is effective for fiscal years beginning after December 15, 2013. Early adoption is not allowed.
	This guidance is a result of the efforts of the FASB and the IASB to develop a consistent approach for determining whether a company is an investment company, for which fair value of investments is the most relevant measurement for the company’s financial statement users. The ASU affects the scope, measurement, and disclosure requirements for investment companies under U.S. GAAP.
	Under the ASU, a company regulated under the Investment Company Act of 1940 is considered an investment company for accounting purposes. All other companies must assess whether they have the following characteristics to be considered an investment company:
	(a) The company obtains funds from investor(s) and provides the investor(s) with investment management services;
	(b) The company commits to its investor(s) that its business purpose and only substantive activities are investing the funds for returns solely from capital appreciation, investment income, or both;
	(c) The company or its affiliates do not obtain or have the objective of obtaining returns or benefits from an investee or its affiliates that are not normally attributable to ownership interests or that are other than capital appreciation or investment income;
	(d) The company has multiple investments;
	(e) The company has multiple investors;
	(f) The company has investors that are not related to the parent or investment manager;
	(g) The company’s ownership interests are in the form of equity or partnership interests; and
	(h) The company manages substantially all of its investments on a fair value basis.
	To be considered an investment company, a company must have all the fundamental characteristics of (a) through (c) above. Typically, an investment company also has characteristics (d) through (h). However, if a company does not possess one or more of the typical characteristics, it must apply judgment and determine, considering all facts and circumstances, how its activities continue to be consistent (or are not consistent) with those of an investment company.
	An investment company also will be required to measure noncontrolling ownership interests in other investment companies at fair value rather than using the equity method of accounting. In addition, an investment company will be required to make the following additional disclosures: (a) the fact that the company is an investment company and is applying specialized guidance; (b) information about changes, if any, in a company’s status as an investment company; and (c) information about financial support provided or contractually required to be provided by an investment company to any of its investees.
	In July 2013, The FASB has published Accounting Standards Update 2013-09, Fair Value Measurement (Topic 820): Deferral of the Effective Date of Certain Disclosures for Nonpublic Employee Benefit Plans in Update No. 2011-04. This ASU defers indefinitely certain disclosures about investments held by nonpublic employee benefit plans in their plan sponsors’ own nonpublic equity securities. The ASU was approved by the FASB on June 12, 2013. ASU No. 2013-09, Fair Value Measurement (Topic 820): Deferral of the Effective Date of Certain Disclosures for Nonpublic Employee Benefit Plans in Update No. 2011-04, applies to disclosures of certain quantitative information about the significant unobservable inputs used in Level 3 fair value measurement for investments held by certain employee benefit plans.
	In July 2013, The FASB has issued Accounting Standards Update (ASU) No. 2013-10, Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (a consensus of the FASB Emerging Issues Task Force). The amendments in this ASU permit the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to UST and LIBOR. The amendments also remove the restriction on using different benchmark rates for similar hedges.
	Before the amendments in this ASU, only UST and, for practical reasons, the LIBOR swap rate, were considered benchmark interest rates. Including the Fed Funds Effective Swap Rate (OIS) as an acceptable U.S. benchmark interest rate in addition to UST and LIBOR will provide risk managers with a more comprehensive spectrum of interest rate resets to utilize as the designated benchmark interest rate risk component under the hedge accounting guidance.
	The amendments apply to all entities that elect to apply hedge accounting of the benchmark interest rate. The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013.
	In July 2013, The FASB has issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force).
	U.S. GAAP does not include explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The amendments in this ASU state that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.
	This ASU applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted.
	In March 2014, FASB has issued Accounting Standards Update (ASU) No. 2014-07, Applying Variable Interest Entities Guidance to Common Control Leasing Arrangements. The guidance addresses the consolidation of lessors in certain common control leasing arrangements and is based on a consensus reached by the Private Company Council (PCC). Under current U.S. GAAP, a company is required to consolidate an entity in which it has a controlling financial interest. The assessment of controlling financial interest is performed under either: (a) a voting interest model; or (b) a variable interest entity model. In a variable interest entity model, the company has a controlling financial interest when it has: (a) the power to direct the activities that most significantly affect the economic performance of the entity; and (b) the obligation to absorb losses or the right to receive benefits of the entity that could be potentially significant to the entity. To determine which model applies, a company preparing financial statements must first determine whether it has a variable interest in the entity being evaluated for consolidation and whether that entity is a variable interest entity. If elected, the accounting alternative should be applied to all leasing arrangements meeting the above conditions. The alternative should be applied retrospectively to all periods presented, and is effective for annual periods beginning after December 15, 2014, and interim periods within annual periods beginning after December 15, 2015. Early application is permitted for all financial statements that have not yet been made available for issuance.
	Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Recovered_Sheet3

Summary of Significant Accounting Policies: Principles of Consolidation: Schedule of Variable Interest Entities (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Schedule of Variable Interest Entities	'
		Place of	Attributable equity	Registered
	Name of subsidiary	Incorporation	interest %	capital
	Obio Pharmaceutical (H.K.) Ltd	Hong Kong	100	$1
	Beijing Obio Pharmaceutical Co., Ltd	PRC	100	$200,000

Recovered_Sheet4

Summary of Significant Accounting Policies: Property, Plant and Equipment: Property, Plant and Equipment, Estimated Useful Lives (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Property, Plant and Equipment, Estimated Useful Lives	'
	Office equipment             5 years
	Testing equipment            5 years

Recovered_Sheet5

Summary of Significant Accounting Policies: Foreign Currency Translation: Schedule of Differences between Reported Amount and Reporting Currency Denominated Amount (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Schedule of Differences between Reported Amount and Reporting Currency Denominated Amount	'
		31-Mar-14	December 31, 2013	31-Mar-13
	Twelve months ended	-	7.7548	-
	HKD : USD exchange rate
	Three months ended	7.7584	-	7.7641
	HKD : USD exchange rate
	Average three months ended	7.75922	-	7.75613
	HKD : USD exchange rate
	Twelve months ended	-	6.114	-
	RMB : USD exchange rate
	Three months ended	6.1644	-	6.2816
	RMB : USD exchange rate
	Average three months ended	6.11985	-	6.28582
	RMB : USD exchange rate

Property_Plant_and_Equipment_N1

Property, Plant and Equipment, Net: Property, Plant and Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Property, Plant and Equipment	'
			As of March 31, 2014		As of December 31, 2013
			-----------------------		-----------------------
	Cost
	Plant and Machinery	$	3,891	$	3,893
	Furniture, fixtures and equipment		1,810		1,825
	Office equipment		5,285		5,311
			-----------------------		-----------------------
			10,986		11,029
	Accumulated depreciation		-10,510		-10,387
			-----------------------		-----------------------
		$	476	$	642
			=====		=====

Patents_Net_Schedule_of_Patent

Patents, Net: Schedule of Patents (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Schedule of Patents	'
			As of March 31, 2014		As of December 31, 2013
			----------------------------		---------------------------
	Cost
	Patents	$	470,555	$	460,801
	License		67,024		67,055
			-----------------------		-----------------------
			537,579		527,856
	Accumulated amortization		-49,017		-44,841
			-----------------------		-----------------------
		$	488,562	$	483,015
			=====		=====

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments: Schedule of Fair Value Measurements and Disclosures (Tables)	3 Months Ended
	Mar. 31, 2014
Tables/Schedules	'
Schedule of Fair Value Measurements and Disclosures	'
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange.
	Level 2 - Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs.
	Level 3 - Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights.

Uncertainty_of_Ability_To_Cont1

Uncertainty of Ability To Continue As A Going Concern (Details) (USD $)	Mar. 31, 2014
Details	'
Retained Earnings (Accumulated Deficit)	($2,751,961)

Recovered_Sheet6

Summary of Significant Accounting Policies: Principles of Consolidation: Schedule of Variable Interest Entities (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Obio Pharmaceutical (H.K.) Ltd	'
Attributable Equity Interest	100.00%
Registered Capital	$1
Beijing Obio Pharmaceutical Co	'
Attributable Equity Interest	100.00%
Registered Capital	$200,000

Property_Plant_and_Equipment_N2

Property, Plant and Equipment, Net: Property, Plant and Equipment (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment, Gross	$10,986	$11,029
Accumulated depreciation	-10,510	-10,387
Property, plant and equipment, net	476	642
Building	'	'
Cost	3,891	3,893
Furniture and Fixtures	'	'
Cost	1,810	1,825
Office Equipment	'	'
Cost	$5,285	$5,311

Property_Plant_and_Equipment_N3

Property, Plant and Equipment, Net (Details) (USD $)	3 Months Ended		12 Months Ended	79 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014
Details	'	'	'	'
Depreciation	$162	$327	$995	$10,290

Patents_Net_Schedule_of_Patent1

Patents, Net: Schedule of Patents (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Details	'	'
Patents	$470,555	$460,801
License	67,024	67,055
Patents, gross	537,579	527,856
Accumulated Amortization	-49,017	-44,841
Patents, net	$488,562	$483,015

Patents_Net_Details

Patents, Net (Details) (USD $)	3 Months Ended		12 Months Ended	79 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014
Details	'	'	'	'
Amortization	$4,197	$3,305	$15,162	$48,972
Written off on patents	'	($618)	'	$54,223

Amounts_Due_To_Directors_Offic1

Amounts Due To Directors, Officers and Shareholder (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Details	'	'
Due to Officers or Stockholders	$1,307,797	$1,253,020

Common_Stock_Details

Common Stock (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Details	'	'
Common stock, shares issued	150,000,000	150,000,000
Common stock, par value	$0.00	$0.00
Common stock	$150,000	$150,000
Additional paid-in capital	($144,858)	($144,858)

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2013		Dec. 31, 2014
Details	'		'
Company secretarial fee paid to related parties	$503	[1]	$507	[1]
[1]	The company secretarial fee was paid to related companies controlled by Chan Kin Man, Eddie, a director of the stockholder